Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries
CONCLUSIONSIn a large population of older patients with type 2 diabetes, 45% were highly adherent during the first year of SGLT2i treatment. Female sex and Black race/ethnicity were most strongly associated with low adherence.
Source: Diabetes Care - Category: Endocrinology Source Type: research
More News: Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Medicare | SGLT2 Inhibitors | Sodium | Statin Therapy | Women